로딩 중…
지수 로딩 중…
NEOFECT Co.,Ltd
290660· KOSDAQ· Health Care· Health Care Equipment & Services
₩1,205+0.00%
2026-11-02
Financials
Valuation Metrics
NEOFECT Co.,Ltd's Market Cap is ₩516B. At end of 2025 it was ₩620B. Ranked #1682 of 2,410 in KR market (top 70%), #1012 of 1,631 on KOSDAQ (top 62%), #67 of 94 in Health Care Equipment & Services (top 71%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 51.62B KRW | KR#1,682/2,410 Sec#67/94 |
| Revenue | 12.63B KRW | KR#2,242/2,410 Sec#78/94 |
| Net Income | -5.63B KRW | KR—/2,410 Sec—/94 |
| Total Assets | 96.46B KRW | KR#1,813/2,410 Sec#54/94 |
| Net Assets | 55.16B KRW | KR#1,840/2,410 Sec#58/94 |
| Employees | 49 | KR#2,056/2,410 Sec#82/94 |
| Value | ||
| P/B | 0.94x | KR#1,501/2,410 Sec#40/94 |
| P/S | 4.09x | KR#2,116/2,410 Sec#69/94 |
| FCF Yield | -4.62% | KR—/2,410 Sec—/94 |
| Profitability | ||
| ROE | -10.20% | KR#1,941/2,410 Sec#67/94 |
| ROA | -5.83% | KR#1,967/2,410 Sec#66/94 |
| Op. Margin | -47.82% | KR#2,221/2,410 Sec#78/94 |
| Revenue Growth | -42.44% | KR#2,261/2,410 Sec#89/94 |
| Financial Health | ||
| Debt Ratio | 74.88% | KR#1,275/2,410 Sec#69/94 |
| Total Debt | 19.08B KRW | KR#1,391/2,410 Sec#41/94 |
| FCF | -2.39B KRW | KR#1,356/2,410 Sec#43/94 |
| Cash | 16.66B KRW | KR#1,369/2,410 Sec#38/94 |
| Current Ratio | 1.35x | KR#1,319/2,410 Sec#68/94 |
| Performance | ||
| 1Y Return | -26.88% | KR#1,286/2,410 Sec#41/94 |
| 1M Return | -7.66% | KR#959/2,410 Sec#36/94 |
| From 52W High | -65.37% | KR#1,870/2,410 Sec#70/94 |
| 1Y MDD | -67.95% | KR#1,861/2,410 Sec#67/94 |
| Trading | ||
| Volume | 205,076 shares | KR#306/2,410 Sec#12/94 |
| Trading Value | 245.0M KRW | KR#1,019/2,410 Sec#37/94 |
| Foreign Own. | 0.00% | KR—/2,410 Sec—/94 |
| Per Share | ||
| EPS | -131 KRW | KR—/2,410 Sec—/94 |
| BPS | 1,288 KRW | KR#2,241/2,410 Sec#85/94 |
Company Info
Established in 2010 and listed on KOSDAQ in 2018, the company researches, develops, produces, and sells AI and IoT-based rehabilitation medical devices. Its Neopect Smart series offers customized rehabilitation for neurological and musculoskeletal patients through engaging game content. The company is also developing electronic control software as a new business, strengthening its market competitiveness through AUTOSAR platform-based software standardization. Neofect is headquartered in Seongnam, Gyeonggi-do.